Notably, it emerges as a pivotal metabolic target of the tumor suppressor protein p53, known for its role in inhibiting tumor progression by curtailing glycolytic activity and fostering OXPHOS through diverse mechanisms [31]. Here, TCHP is linked to neoplasm.